chitosan has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlert, TA; Chen, D; Cormier, SA; Giaimo, JD; Hellermann, G; Kong, X; Li, X; Lockey, RF; Mohapatra, S; Mohapatra, SS; Wang, X; Xu, W | 1 |
| C, SK; Henry, LJK; Kandasamy, R; M, GA; Natesan, S | 1 |
2 other study(ies) available for chitosan and atrial natriuretic factor
| Article | Year |
|---|---|
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma.
Topics: Administration, Intranasal; Animals; Asthma; Atrial Natriuretic Factor; Bronchoconstrictor Agents; Cell Line; Chitosan; Cytokines; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Humans; Luciferases; Methacholine Chloride; Mice; Mice, Inbred BALB C; Nanoparticles; Ovalbumin; Peptide Fragments; Pneumonia; Receptors, Atrial Natriuretic Factor; Respiratory Hypersensitivity; Reverse Transcriptase Polymerase Chain Reaction; Th2 Cells; Transfection | 2009 |
Atrial natriuretic peptide-conjugated chitosan-hydrazone-mPEG copolymer nanoparticles as pH-responsive carriers for intracellular delivery of prednisone.
Topics: A549 Cells; Atrial Natriuretic Factor; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Hydrazones; Hydrogen-Ion Concentration; Nanoparticles; Polymers; Prednisone | 2017 |